SeekingAlpha · Sep 29, 2026
DN
NYSE · DNA
Ginkgo Bioworks Holdings, Inc.
Healthcare · Biotechnology
$14.98
Down-$2.57 (-17.16%)
Updated Oct 6, 2026, 10:56 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 539.91M
- P/E ratio
- -1.62
- Dividend yield
- 0.00%
- 52-week range
- $5.37 – $17.58
- Volume
- 7.69M
- Avg. volume
- 1.4M
Price performance · DNA
DNA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
DNA closed at $14.98 after 20 trading sessions, up 115.85% for the selected period.
- Last close
- $14.98
- Period change
- +115.85%
- Period low
- $6.75
- Period high
- $14.98
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $12.50 | $15.48 | $12.48 | $14.98 | 7.69M |
| Oct 2, 2026 | $13.00 | $13.40 | $11.94 | $12.35 | 2.04M |
| Oct 1, 2026 | $12.60 | $13.16 | $12.11 | $12.50 | 2.92M |
| Sep 30, 2026 | $11.90 | $13.415 | $11.865 | $12.83 | 4.65M |
| Sep 29, 2026 | $10.54 | $12.2699 | $10.53 | $11.96 | 4.75M |
| Sep 28, 2026 | $10.375 | $10.79 | $10.095 | $10.46 | 2.12M |
| Sep 25, 2026 | $10.20 | $10.67 | $9.5401 | $10.66 | 2.31M |
| Sep 24, 2026 | $8.50 | $10.44 | $8.44 | $10.25 | 4.03M |
| Sep 23, 2026 | $9.13 | $9.28 | $8.54 | $8.58 | 1.85M |
| Sep 22, 2026 | $7.87 | $9.80 | $7.80 | $9.37 | 3.33M |
| Sep 21, 2026 | $8.05 | $8.1256 | $7.67 | $7.98 | 1.65M |
| Sep 18, 2026 | $7.83 | $7.98 | $7.495 | $7.88 | 1.76M |
| Sep 17, 2026 | $7.29 | $8.14 | $7.2091 | $7.84 | 2.66M |
| Sep 16, 2026 | $7.10 | $7.3909 | $6.95 | $7.06 | 976.22K |
| Sep 15, 2026 | $6.95 | $7.18 | $6.91 | $6.99 | 734.93K |
| Sep 14, 2026 | $6.66 | $7.14 | $6.66 | $7.01 | 1.03M |
| Sep 11, 2026 | $6.80 | $6.83 | $6.52 | $6.75 | 932.66K |
| Sep 10, 2026 | $6.72 | $6.85 | $6.59 | $6.78 | 679.47K |
| Sep 9, 2026 | $6.83 | $6.93 | $6.72 | $6.79 | 894.18K |
| Sep 8, 2026 | $7.00 | $7.06 | $6.75 | $6.94 | 1.08M |
Latest DNA news
The latest Smart Investors Daily articles mentioning DNA.
Stock researchCompany · Overview
Company
Market Activity
Research & News
DNA research
Overview
Company profile and research snapshot.
Company profile
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $9.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 4, 2026 | BTIG | Sell | — |
| Aug 7, 2026 | TD Cowen | Hold | — |
| Mar 12, 2026 | BTIG | Sell | — |
| Jan 8, 2026 | TD Cowen | Buy | — |
| Aug 25, 2025 | BTIG | Sell | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 23, 2026
Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $8.58, marking a -8.43% move from the previous day.
Yahoo · Sep 18, 2026
Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains?
Ginkgo Bioworks (DNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Yahoo · Sep 16, 2026
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts
Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $7.06, signifying a +1% move from its prior day's close.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
